Video: BioNTech's Marett On Sanofi Deal And Immunotherapy
This article was originally published in Scrip
In this video interview BioNTech chief operating officer, Sean Marett, discusses his company's recent Sanofi immunotherapy deal with Mike Ward, global director of content for Informa Pharma Insights, at BIO-Europe in Munich, Germany. They chat about BioNTech's messenger RNA technology, co-development plans with Sanofi and the potential for immunotherapy combination studies.
Look out for more BIO-Europe exclusive interviews all this week on Scrip. To see more video interviews and panel discussions from BIO-Europe 2015 right now visit Partnering360.